Business Wire

MYT-NETHERLANDS-PARENT

18.5.2021 12:02:07 CEST | Business Wire | Press release

Share
Q3, FY 2021 Results: Mytheresa Reports Exceptional Net Sales Growth of 47.5% in Q3, FY 2021 Benefiting From the Accelerated Shift in Consumer Behavior Towards Digital and Increases Full Year Guidance

MYT Netherlands Parent B.V. (NYSE: MYTE) (“Mytheresa” or the “Company”), the parent company of Mytheresa Group GmbH, today announced financial results for its third quarter of FY 2021 ended March 31, 2021. The luxury online fashion business continued to benefit from the shift in consumer shopping behavior towards digital offerings, which shaped the strong results of the third quarter. Even taking into account the lower comparables of Q3 in FY2020 the accelerated growth is evidenced by the two-year growth rate of 66% versus the two-year growth rate of 60% for the second quarter of FY 2021.

Michael Kliger, Chief Executive Officer of Mytheresa, said: “In the third quarter, our company was even able to accelerate our growth. This was largely driven by the continuous shift of consumer behavior towards digital and multi-brand offerings. We had a new record in first-time buyers in the quarter and our recently acquired customer cohorts show higher re-purchase rates than before. Additionally, we are seeing a strongly increased spend from our top customers as they begin to resume pre-pandemic activities such as social events and vacation. We grew strongly in almost all geographies, especially in the US, where we saw net sales growth of over 76%.”

Kliger continued, “Even when we adjust for the relatively low comparables of the third quarter in 2020 it is very clear that our positioning as a curated, multi-brand luxury platform gives us both strategically and financially a fantastic position to capitalize both on the short-term as well long-term growth opportunities in the market. Our success continues to be based on a sharp luxury customer focus, strong brand partnerships and an execution-driven and profit-making business model. The extraordinary results of the third quarter demonstrate our strong position as the leading curated platform for luxury fashion. Accordingly, we have raised our guidance for the full fiscal year 2021.”

FINANCIAL HIGHLIGHTS FOR THE THIRD QUARTER ENDED MARCH 31, 2021

  • Net sales increase of 47.5% year-over-year to €164.8 million
  • Stable gross margin of 43.9%
  • Adjusted EBITDA of €11.1 million, as compared to €3.1 million in the prior year period
  • Adjusted EBITDA margin of 6.8%, as compared to 2.8% in the prior year period
  • Adjusted operating income of €9.1 million, as compared to €1.2 million in the prior year period
  • Adjusted net income of €4.5 million, as compared to adjusted net loss of €0.1 million in the prior year period

FINANCIAL HIGHLIGHTS FOR THE NINE MONTHS ENDED MARCH 31, 2021

  • Net sales increase of 36.2% year-over-year to €449.7 million
  • LTM Active customer growth at 34.1% with 621,000 active customers
  • Stable gross margin of 46.6%
  • Adjusted EBITDA of €43.7 million, as compared to €20.3 million in the prior year period
  • Adjusted EBITDA margin of 9.7%, as compared to 6.2% in the prior year period
  • Adjusted operating income of €37.6 million, as compared to €14.6 million in the prior year period.
  • Adjusted net income of €24.5 million, as compared to €9.9 million in the prior year period

RECENT BUSINESS HIGHLIGHTS

Continued Global Expansion:

  • Accelerating growth across all geographies with 47.5% in net sales compared to Q3, FY 2020
  • Outstanding growth in the United States with 75.8% increase in net sales
  • Further investments in Mytheresa’s United States presence, including the appointment of a President North America, effective June 1, 2021

Strong Brand Partnerships:

  • Strong ongoing support of brand partners with the launch of exclusive capsule collections and pre-launches in collaboration with Burberry, Bottega Veneta, Marine Serre x Jimmy Choo, The Attico, Totême, Simone Rocha and Loewe as well as the launch of Dior Eyewear
  • Digital events targeting top customers in collaboration with Roger Vivier, Johanna Ortiz, Simone Rocha and Repossi

High-quality Customer Growth:

  • Growth of active customers by 34% year-over-year to 621,000 (LTM)
  • Record growth of first-time buyers in Q3, FY 2021, surpassing Q2’s record of over 100,000
  • Growth in average net sales per customer across all customer groups and especially with top customers in Q3, FY 2021 (+10% YoY)
  • Newly acquired customer cohorts show better re-purchase rates compared to the previous year cohorts

Consistent Strong Performance:

  • Maintained business continuity across all operations with focus in health and well-being of all Mytheresa employees as top priority during the third wave of the pandemic
  • Further decreased customer acquisition costs, stable average order value (AOV) and declining return rates in womenswear
  • Significant increase in customer satisfaction with a Net Promoter Score of 86% in Q3, FY 2021

BUSINESS OUTLOOK

The impacts of the Covid-19 epidemic are difficult to assess, as the scale, duration and geographic extent of the crisis evolve every day. For the full fiscal year ending June 30, 2021, Mytheresa has raised its guidance as the result of its strong Q3 performance:

  • Net sales in the range of €600 million to €605 million, representing 33% to 35% growth
  • Adjusted EBITDA in the range of €55 million to €59 million
  • Adjusted EBITDA Margin of 9.1% to 9.8%

The foregoing forward-looking statements reflect Mytheresa’s expectations as of today's date. Given the number of risk factors, uncertainties and assumptions discussed below, actual results may differ materially. Mytheresa does not intend to update its forward-looking statements until its next quarterly results announcement, other than in publicly available statements.

CONFERENCE CALL AND WEBCAST INFORMATION

Mytheresa will host a conference call to discuss its third quarter fiscal 2021 financial results on May 18, 2021 at 8:00am Eastern Time. Those wishing to participate via webcast should access the call through Mytheresa’s Investor Relations website at https://investors.mytheresa.com . Those wishing to participate via the telephone may dial in at +1 (833) 979-2860 (USA) or +1 (236) 714-2917 (International). A replay will be available via webcast through Mytheresa’s Investor Relations website. The telephone replay will be available from 11:00am Eastern Time on May 18, 2021, through May 25, 2021, by dialing +1 (800) 585-8367 (USA) or +1 (416) 621-4642 (International). The replay passcode will be 5887405.

FORWARD LOOKING STATEMENTS

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements relating to the impact of the COVID-19 global pandemic; future sales, expenses, and profitability; future development and expected growth of our business and industry; our ability to execute our business model and our business strategy; having available sufficient cash and borrowing capacity to meet working capital, debt service and capital expenditure requirements for the next twelve months; and projected capital spending. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements are only predictions Actual events or results may differ materially from those stated or implied by these forward-looking statements. In evaluating these statements and our prospects, you should carefully consider the factors set forth below.

We undertake no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.

The achievement or success of the matters covered by such forward-looking statements involves known and unknown risks, uncertainties and assumptions. If any such risks or uncertainties materialize or if any of the assumptions prove incorrect, our results could differ materially from the results expressed or implied by the forward-looking statements we make.

You should not rely upon forward-looking statements as predictions of future events. Forward-looking statements represent our management’s beliefs and assumptions only as of the date such statements are made.

Further information on these and other factors that could affect our financial results is included in filings we make with the U.S. Securities and Exchange Commission (“SEC”) from time to time, including the section titled “Risk Factors” in our final prospectus under Rule 424(b) filed with the SEC on January 22, 2021 in connection with our IPO and 6-K (reporting our quarterly results). These documents are available on the SEC’s website at www.sec.gov and on the SEC Filings section of the Investor Relations section of our website at: https://investors.mytheresa.com .

ABOUT NON-IFRS FINANCIAL MEASURES

We review a number of operating and financial metrics, including the following business and non-IFRS metrics, to evaluate our business, measure our performance, identify trends affecting our business, formulate business plans and make strategic decisions. We present Adjusted EBITDA, Adjusted Operating Income, and Adjusted Net Income because they are frequently used by analysts, investors and other interested parties to evaluate companies in our industry. Further, we believe these measures are helpful in highlighting trends in our operating results, because they exclude the impact of items that are outside the control of management or not reflective of our ongoing operations and performance. Adjusted EBITDA, Adjusted Operating Income, and Adjusted Net Income have limitations, because they exclude certain types of expenses. Furthermore, other companies in our industry may calculate similarly titled measures differently than we do, limiting their usefulness as comparative measures. We use Adjusted EBITDA, Adjusted Operating Income, and Adjusted Net Income as supplemental information only. You are encouraged to evaluate each adjustment and the reasons we consider it appropriate for supplemental analysis.

Our non-IFRS financial measures include:

  • Adjusted EBITDA is a non-IFRS financial measure that we calculate as net income before finance expense (net), taxes, and depreciation and amortization, adjusted to exclude U.S. sales tax expenditures temporarily borne by us through the fourth quarter of fiscal 2020, IPO preparation and transaction costs and share-based compensation expenses.
  • Adjusted Operating Income is a non-IFRS financial measure that we calculate as operating income, adjusted to exclude U.S. sales tax expenditures temporarily borne by us through the fourth quarter of fiscal 2020, any IPO preparation and transaction costs and share-based compensation expenses.
  • Adjusted Net Income is a non-IFRS financial measure that we calculate as net income, adjusted to exclude U.S. sales tax expenditures temporarily borne by us, finance expenses on our Shareholder Loans, IPO preparation and transaction costs, share-based compensation expenses and related income tax effects.
  • We are not able to forecast net income (loss) on a forward-looking basis without unreasonable efforts due to the high variability and difficulty in predicting certain items that affect net income (loss), including, but not limited to, Income taxes and Interest expense.

ABOUT MYTHERESA

Mytheresa is one of the leading global luxury fashion e-commerce platforms. Mytheresa was launched in 2006 and offers ready-to-wear, shoes, bags and accessories for women, men and kids. The highly curated edit focuses on true luxury with designer brands such as Bottega Veneta, Burberry, Dolce & Gabbana, Fendi, Gucci, LOEWE, Loro Piana, Moncler, Prada, Saint Laurent, Valentino and many more. Mytheresa's unique digital experience is based on a sharp focus on high-end luxury shoppers, exclusive product and content offerings, leading technology and analytical platforms as well as high quality service operations.

For more information, please visit https://investors.mytheresa.com/ .

MYT Netherlands Parent B.V.

Financial Results and Key Operating Metrics

(Amounts in € millions)

 

Three Months Ended

 

Nine Months Ended

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2020

 

March 31, 2021

 

Change
in % / BPs

 

March 31, 2020

 

March 31, 2021

 

Change
in % / BPs

 

 

 

 

 

 

 

 

 

 

 

 

(in millions) (unaudited)

 

 

 

 

 

 

 

 

 

 

 

Active customer (LTM in thousands)

463

 

621

 

34.1%

 

463

 

621

 

34.1%

Total orders shipped (LTM in thousands)

1,046

 

1,384

 

32.3%

 

1,046

 

1,384

 

32.3%

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

€ 111.7

 

€ 164.8

 

47.5%

 

€ 330.2

 

€ 449.7

 

36.2%

Gross profit

€ 49.9

 

€ 72.4

 

44.9%

 

€ 154.7

 

€ 209.6

 

35.5%

Gross profit margin(1)

44.7%

 

43.9%

 

(80 BPs)

 

46.8%

 

46.6%

 

(20 BPs)

Adjusted EBITDA(2)

€ 3.1

 

€ 11.1

 

257.1%

 

€ 20.3

 

€ 43.7

 

114.9%

Adjusted EBITDA margin(1)

2.8%

 

6.8%

 

400 BPs

 

6.2%

 

9.7%

 

350 BPs

Adjusted Operating Income(2)

€ 1.2

 

€ 9.1

 

635.1%

 

€ 14.6

 

€ 37.6

 

157.6%

Adjusted Operating Income margin(1)

1.1%

 

5.5%

 

440 BPs

 

4.4%

 

8.4%

 

400 BPs

Adjusted Net Income(2)

€ (0.1)

 

€ 4.5

 

N/A

 

€ 9.9

 

€ 24.5

 

148.1%

Adjusted Net Income margin(1)

(0.1%)

 

2.7%

 

280 BPs

 

3.0%

 

5.5%

 

250 BPs

 

(1) As a percentage of net sales.

(2) EBITDA, adjusted EBITDA, adjusted Operating Income, adjusted net income are measures not defined under IFRS. For further information about how we calculate these measures and limitations of its use, see below.

MYT Netherlands Parent B.V.

Financial Results and Key Operating Metrics

(Amounts in € millions)

The following are reconciliations of Adjusted EBITDA, Adjusted Operating Income, and Adjusted Net Income to their most directly comparable IFRS measures:

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2020

 

March 31, 2021

 

Change
in %

 

March 31, 2020

 

March 31, 2021

 

Change
in %

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(in millions) (unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

€ (6.7)

 

€ (50.0)

 

642.7%

 

€ (4.7)

 

€ (24.6)

 

422.6%

 

Finance expenses, net

€ 5.5

 

€ (4.6)

 

(183.5%)

 

€ 11.5

 

€ (14.8)

 

(228.4%)

Income tax expense

€ (0.2)

 

€ 3.8

 

N/A

 

€ 0.7

 

€ 13.5

 

N/A

Depreciation and amortization

€ 1.9

 

€ 2.0

 

8.4%

 

€ 5.7

 

€ 6.1

 

6.3%

thereof depreciation of right-

of use assets

€ 1.3

 

€ 1.3

 

1.7%

 

€ 3.7

 

€ 3.9

 

4.9%

 

EBITDA

€ 0.5

 

€ (48.7)

 

N/A

 

€ 13.2

 

€ (19.8)

 

(250.1%)

 

 

U.S. sales tax(1)

€ 0.4

 

€ 0.0

 

(100.0%)

 

€ 2.1

 

€ 0.0

 

(100.0%)

 

 

IPO preparation and transaction

costs(2)

€ 2.2

 

€ 3.3

 

47.2%

 

€ 5.0

 

€ 7.0

 

40.7%

 

 

IPO related share-based

compensation(3)

€ 0.0

 

€ 56.5

 

N/A

 

€ 0.1

 

€ 56.6

 

N/A

 

 

Adjusted EBITDA

€ 3.1

 

€ 11.1

 

257.1%

 

€ 20.3

 

€ 43.7

 

114.9%

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2020

 

March 31, 2021

 

Change
in %

 

March 31, 2020

 

March 31, 2021

 

Change
in %

 

 

 

 

 

 

 

 

 

 

 

 

(in millions) (unaudited)

 

 

 

 

 

 

 

 

 

 

 

Operating Income

€ (1.4)

 

€ (50.7)

 

N/A

 

€ 7.5

 

€ (25.9)

 

(447.6%)

U.S. sales tax(1)

€ 0.4

 

€ 0.0

 

(100.0%)

 

€ 2.1

 

€ 0.0

 

(100.0%)

IPO preparation and transaction

costs(2)

€ 2.2

 

€ 3.3

 

47.2%

 

€ 5.0

 

€ 7.0

 

40.7%

IPO related share-based

compensation(3)

€ 0.0

 

€ 56.5

 

N/A

 

€ 0.1

 

€ 56.6

 

N/A

Adjusted Operating Income

€ 1.2

 

€ 9.1

 

635.1%

 

€ 14.6

 

€ 37.6

 

157.6%

MYT Netherlands Parent B.V.

Financial Results and Key Operating Metrics

(Amounts in € millions)

 

Three Months Ended

 

Nine Months Ended

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2020

 

March 31, 2021

 

Change
in %

 

March 31, 2020

 

March 31, 2021

 

Change
in %

 

 

 

 

 

 

 

 

 

 

 

 

(in millions) (unaudited)

 

 

 

 

 

 

 

 

 

 

 

Net Income

€ (6.7)

 

€ (50.0)

 

642.7%

 

€ (4.7)

 

€ (24.6)

 

422.6%

U.S. sales tax(1)

€ 0.4

 

€ 0.0

 

(100.0%)

 

€ 2.1

 

€ 0.0

 

(100.0%)

IPO preparation and transaction

costs(2)

€ 2.2

 

€ 3.3

 

47.2%

 

€ 5.0

 

€ 7.0

 

40.7%

IPO related share-based

compensation (3)

€ 0.0

 

€ 56.5

 

N/A

 

€ 0.1

 

€ 56.6

 

N/A

Finance expenses on shareholder

loans (4)

€ 5.4

 

€ (5.0)

 

(192.6%)

 

€ 11.0

 

€ (16.0)

 

(245.0%)

Income tax effect(5)

€ (1.4)

 

€ (0.4)

 

(72.5%)

 

€ (3.6)

 

€ 1.6

 

(143.7%)

Adjusted Net Income

€ (0.1)

 

€ 4.5

 

N/A

 

€ 9.9

 

€ 24.5

 

148.1%

(1) Represents expenses related to sales tax liabilities temporarily borne by us through the fourth quarter of fiscal 2020 in the United States. We temporarily incurred sales tax related liabilities on customer purchases in the United States because we were not able to charge our customers for these amounts at the point of sale under our previous IT configuration. Due to upgrades in our IT infrastructure during the fourth quarter of fiscal 2020, we no longer incur these expenses, as we charge the applicable U.S. sales tax directly to our customers.

(2) Represents non-recurring professional fees, including consulting, legal and accounting fees, related to this offering, which are classified within selling, general and administrative expenses.

(3) With the effective IPO, certain key management personnel received a one-time granted share-based compensation with €3.2 million other long-term plans canceled. We do not consider these expenses to be indicative of our core operating performance.

(4) Our Adjusted Net Income excludes finance expenses associated with our Shareholder Loans, which we do not consider to be indicative of our core performance. We did not receive any cash proceeds under the Shareholder Loans, which originated as part of the Neiman Marcus acquisition in 2014. In January 2021, we repaid our Shareholder Loans (principal plus outstanding interest) using a portion of the net proceeds from our initial public offering.

(5) Reflects adjustments to historical income tax expense to reflect changes in taxable income for each of the periods presented due to changes in finance expenses related to the Shareholder Loans, assuming a statutory tax rate of 27.8%.

MYT Netherlands Parent B.V.

Unaudited Condensed Consolidated Statements of Profit and Comprehensive Income

(Amounts in € thousands, except share and per share data)

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

 

 

 

 

 

 

 

 

 

(in € thousands)

 

 

 

March 31, 2020

 

March 31, 2021

 

March 31, 2020

 

March 31, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

 

 

111,735

 

164,776

 

330,216

 

449,728

 

 

Cost of sales, exclusive of depreciation and amortization

 

 

 

(61,798)

 

(92,413)

 

(175,553)

 

(240,114)

 

 

Gross profit

 

 

 

49,937

 

72,363

 

154,663

 

209,614

 

 

Shipping and payment cost

 

 

 

(13,129)

 

(19,265)

 

(40,474)

 

(51,931)

 

 

Marketing expenses

 

 

 

(16,199)

 

(22,094)

 

(49,310)

 

(59,231)

 

 

Selling, general and administrative expenses

 

 

 

(20,001)

 

(80,040)

 

(51,796)

 

(117,701)

 

 

Depreciation and amortization

 

 

 

(1,881)

 

(2,040)

 

(5,745)

 

(6,107)

 

 

Other expense (income), net

 

 

 

(124)

 

329

 

120

 

(568)

 

 

Operating income

 

 

 

(1,397)

 

(50,747)

 

7,457

 

(25,925)

 

 

Finance (expense) income, net

 

 

 

(5,522)

 

4,610

 

(11,506)

 

14,768

 

 

Income (loss) before income taxes

 

 

 

(6,919)

 

(46,137)

 

(4,049)

 

(11,157)

 

 

Income tax (expense) income

 

 

 

189

 

(3,838)

 

(663)

 

(13,464)

 

 

Net income (loss)

 

 

 

(6,729)

 

(49,975)

 

(4,711)

 

(24,621)

 

 

Cash Flow Hedge

 

 

 

513

 

(992)

 

(333)

 

(43)

 

 

Income Taxes related to Cash Flow Hedge

 

 

 

(143)

 

211

 

93

 

(20)

 

 

Foreign currency translation

 

 

 

3,520

 

-

 

4,738

 

-

 

 

Other comprehensive income (loss)

 

 

 

3,890

 

(781)

 

4,498

 

(63)

 

 

Comprehensive income (loss)

 

 

 

(2,839)

 

(50,755)

 

(214)

 

(24,683)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted earnings per share

 

 

(0.10)

(0.60)

(0.07)

(0.33)

 

 

Weighted average ordinary shares outstanding (basic and diluted)

 

 

 

70,190,687

 

82,785,116

 

70,190,687

 

74,388,830

 

 

 

MYT Netherlands Parent B.V.

Unaudited Condensed Consolidated Statements of Financial Position

(Amounts in € thousands)

(in € thousands)

 

June 30, 2020

March 31, 2021

Assets

 

Non-current assets

 

Intangible assets and goodwill

 

154,966

154,807

Property and equipment, net

 

 

 

9,570

 

9,046

Right-of-use assets

 

19,001

15,105

Total non-current assets

 

183,537

178,958

Current assets

 

 

 

Inventories

 

 

 

169,131

 

232,557

Trade and other receivables

 

4,815

5,620

Other assets

 

 

 

18,949

 

16,811

Cash and cash equivalents

 

9,367

56,008

Total current assets

 

 

 

202,263

 

310,995

Total assets

 

385,800

489,953

 

 

 

Shareholders’ equity and liabilities

 

 

 

Subscribed capital

 

1

1

Capital reserve

 

 

 

91,008

 

429,514

Accumulated Deficit

 

(28,232)

(52,853)

Other comprehensive income

 

 

 

1,602

 

1,539

Total shareholders’ equity

 

64,377

378,201

 

 

 

Non-current liabilities

 

 

 

 

 

 

Shareholder Loans

 

191,194

-

Other liabilities

 

 

5,906

 

-

Tax liabilities

3,853

3,386

Provisions

 

 

582

 

715

Lease liabilities

13,928

10,090

Deferred tax liabilities, net

 

 

1,130

 

12,293

Total non-current liabilities

216,592

26,483

Current liabilities

 

 

 

 

 

Liabilities to banks

10,000

-

Lease liabilities

 

 

5,787

 

5,297

Contract liabilities

6,758

5,675

Trade and other payables

 

 

36,158

 

25,665

Other liabilities

46,128

48,632

Total current liabilities

 

 

104,831

 

85,269

Total liabilities

321,422

111,752

Total shareholders’ equity and liabilities

 

 

385,800

 

489,953

MYT Netherlands Parent B.V.

Unaudited Condensed Consolidated Statements of Changes in Equity

(Amounts in € thousands)

(in € thousands)

 

Subscribed capital

 

Capital reserve

 

Accumulated deficit

 

Hedging reserve

 

Foreign currency translation reserve

 

Total shareholders’ equity

Balance as of July 1, 2019

 

72

 

148,961

 

(34,584)

 

-

 

(3,122)

 

111,327

Net income

 

-

 

-

 

(4,711)

 

-

 

-

 

(4,711)

Other comprehensive income

 

-

 

-

 

-

 

(240)

 

4,738

 

4,498

Comprehensive income

 

-

 

-

 

(4,711)

 

(240)

 

4,738

 

(214)

Distribution

 

-

 

(191,207)

 

-

 

-

 

-

 

(191,207)

Contribution

 

-

 

96,938

 

-

 

-

 

-

 

96,938

Legal Reorganization

 

(71)

 

36,251

 

-

 

-

 

-

 

36,180

Share-based compensation

 

-

 

58

 

-

 

-

 

-

 

58

Balance as of March 31, 2020

 

1

 

91,001

 

(39,295)

 

(240)

 

1,616

 

(43,856)

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of July 1, 2020

 

1

 

91,008

 

(28,232)

 

-

 

1,602

 

64,377

Net income

 

-

 

-

 

(24,621)

 

-

 

-

 

(24,621)

Other comprehensive income

 

-

 

-

 

-

 

(63)

 

-

 

(63)

Comprehensive income

 

-

 

-

 

(24,621)

 

(63)

 

-

 

(24,683)

Capital increase initial public offering (referred to as IPO)

 

-

 

283,224

 

-

 

-

 

-

 

283,224

IPO related Transaction costs

 

-

 

(4,550)

 

-

 

-

 

-

 

(4,550)

Share-based compensation

 

-

 

59,833

 

-

 

-

 

-

 

59,833

Balance as of March 31, 2021

 

1

 

429,514

 

(52,853)

 

(63)

 

1,602

 

378,201

MYT Netherlands Parent B.V.

Unaudited Condensed Consolidated Statements of Cash Flows

(Amounts in € thousands)

Nine months ended March 31,

(in € thousands)

2020

2021

 

Net (loss) income

 

 

 

(4,711)

 

(24,621)

Non-Cash items

 

 

 

 

 

 

Depreciation and amortization

 

 

 

5,745

 

6,107

Finance expense (income), net

 

 

 

11,506

 

(14,768)

Share-based compensation

 

 

 

58

 

59,833

Income tax (income) expense

 

 

 

663

 

13,464

Change in operating assets and liabilities

 

 

 

 

 

 

Increase in provisions

 

 

 

15

 

133

Increase in inventories

 

 

 

(36,032)

 

(63,425)

Decrease (increase) in trade and other receivables

 

 

 

3,857

 

(805)

Decrease (increase) in other assets

 

 

 

(1,610)

 

2,526

Increase in other liabilities

 

 

 

13,080

 

(3,936)

Increase (decrease) in contract liabilities

 

 

 

247

 

(1,083)

(Decrease) increase in trade and other payables

 

 

 

(13,225)

 

(10,493)

Income taxes paid

 

 

 

(2,325)

 

(2,684)

Net cash (outflow) from operating activities

 

 

 

(22,733)

 

(39,751)

Expenditure for property and equipment and intangible assets

 

 

 

(1,843)

 

(1,555)

Proceeds from sale of property and equipment and intangible assets

 

 

 

-

 

44

Net cash (outflow) from investing activities

 

 

 

(1,843)

 

(1,511)

Interest paid

 

 

 

(3,346)

 

(4,581)

Proceeds from bank liabilities

 

 

 

53,750

 

64,990

Repayment of liabilities from banks

 

 

 

(7,149)

 

(74,990)

Repayment of Shareholder loans

 

 

 

-

 

(171,827)

Proceeds from capital increase

 

 

 

-

 

283,224

IPO preparation and transaction costs

 

 

 

-

 

(4,550)

Lease payments

 

 

 

(3,738)

 

(4,345)

Net cash inflow from financing activities

 

 

 

39,517

 

87,922

Net increase (decrease) in cash and cash equivalents

 

 

 

14,940

 

46,659

Cash and cash equivalents at the beginning of the period

 

 

 

2,120

 

9,367

Effects of exchange rate changes on cash and cash equivalents

 

 

 

(28)

 

(18)

Cash and cash equivalents at end of the period

 

 

 

17,032

 

56,008

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye